Loading mechanism for infusion pump
Abstract
A loading mechanism for a medication infusion pump. The mechanism includes a medication reservoir (30), a plunger (35), a threaded plunger rod (40) offset from the axis of the reservoir and an infusion pump with a drive screw (50) that is offset from the axis of a pump barrel. The pump barrel receives the assembly comprising the reservoir, plunger and plunger rod.

Term
Term ended
Projected expiry passed 23 December 2022, 3.8 years ago.
- Priority
- Filed
- Published
- Projected expiry
- Today
5 claims: 1 independent, 4 dependent
- 1A reservoir assembly for infusing fluids comprising:a reservoir of variable volume, the reservoir characterized by a longitudinal reservoir axis;a plunger connected to the bottom of the reservoir so as to cause a change in volume in the reservoir when the plunger is axially displaced;a threaded plunger rod coupled to the plunger, the plunger rod threads capable of engagement with a drive screw having exterior threads and an axis displaced from and parallel to the reservoir axis;anda locking hub connected to the reservoir and capable of engaging and disengaging the plunger rod threads with the drive screw threads.
23 paragraphs, as filed
<u style="single">Technical Field and Background Art</u>
The present invention relates to medical infusion pumps and more particularly to improved devices for loading medication reservoirs.
Medical infusion pumps have been advantageously employed, for example, to simulate the action of the human pancreas, providing a continuous delivery of insulin to patients with diabetes. These pumps typically include a microprocessor controlled syringe pump, an insulin filled syringe, a hub and tubing set and a cannula. The pump is often worn in a carrying case on the patient's belt or in other locations such as a pocket. The syringe is mounted in the syringe pump and can contain enough insulin for several days. The hub connects the syringe to the tubing set. The cannula is at the end of the tubing set and can be either steel or softer teflon. The cannula is inserted into fatty tissue and the insulin is injected subcutaneously.
Prior art infusion pumps have been cumbersome to load, requiring a series of steps that often require the user to carefully align components of a pump drive assembly with the syringe.
<u style="single">Summary of the Invention</u>
In a first embodiment of the invention there is provided a drive assembly for an infusion pump. The drive assembly includes a pump barrel that has a clearance hole for receiving and guiding a threaded plunger rod. A threaded, rotating drive screw is provided whose longitudinal axis is parallel to and offset from the pump barrel axis. The plunger rod engages and disengages the drive screw when the pump barrel is rotated, thereby rotating the rod about the longitudinal axis of the barrel. This embodiment of the invention may be used, for example, in devices for injecting medication and delivering other fluid materials such as caulk, cement, grease, etc.
In another embodiment of the invention, the drive assembly of the first embodiment further comprises a variable volume reservoir including a plunger. The plunger is connected to the plunger rod, which rod varies the volume of the reservoir as the plunger is displaced. A locking hub is provided that connects to the top of the reservoir. The locking hub contacts the pump barrel, rotating the barrel and forcing the rod into and out of engagement with the drive screw. The reservoir is loaded into the pump by aligning the plunger rod with the hub, inserting the reservoir into the pump barrel with the plunger rod guided by the clearance hole, and rotating the hub to lock the reservoir into the pump.
In a further embodiment of the invention, the drive screw threads and the rod threads of the first embodiment are buttress threads.
In another embodiment of the invention, the pump barrel of the first embodiment has a locking tab to inhibit rotation of the barrel about the longitudinal barrel axis.
In a further embodiment of the invention, a variable volume reservoir is provided together with a plunger connected to the bottom of the reservoir. A threaded plunger rod is also provided that is connected to the plunger, such that the plunger rod is parallel to and offset from the longitudinal axis of the reservoir. The plunger rod is capable of mating with a threaded drive screw whose axis is offset from and parallel to the longitudinal axis of the reservoir. The plunger rod, when axially displaced, causes a change in volume of the reservoir. This embodiment of the invention can be used in combination with a drive assembly to deliver a fluid.
<u style="single">Brief Description of the Drawings</u>
The foregoing features of the invention will be more readily understood by reference to the following detailed description, taken with reference to the accompanying drawings, in which: <ul id="ul0001" list-style="none" compact="compact"><li>Fig. 1 is a top-level view of an infusion pump according to an embodiment of the invention;</li><li>Fig. 2 is an exploded view of a drive mechanism for the infusion pump of fig. 1.;</li><li>Fig. 3 shows an embodiment of a pump barrel locking mechanism;</li><li>Fig. 4 shows the relation of the drive screw to the plunger rod for the infusion pump of fig. 1;</li><li>Fig. 5 shows a connection from a reservoir to a tubing set;</li><li>Fig. 6 illustrates another method of connecting a reservoir to a tubing set;</li><li>Fig. 7 shows an adapter for using a small diameter reservoir with the pump assembly according to another embodiment of the invention; and</li><li>Fig. 8a is an on-axis view of the adapter of fig. 7.</li><li>Fig. 8b shows the adapter of fig. 7 with the drive screw disengaged from the plunger rod.</li></ul>
<u style="single">Detailed Description of Specific Embodiments</u>
Embodiments of the present invention advantageously address simplifying the loading of medication reservoirs in an infusion pump.
Fig. 1 is an overall view of an infusion pump according to an embodiment of the present invention. A pump assembly <b>10</b> contains the components needed to cause a reservoir assembly <b>15</b> to deliver medication to a user. The reservoir assembly <b>15</b> may contain enough medication, such as insulin, for several days for a typical user. A tubing set <b>20</b>, connected to the reservoir assembly, contains the cannula through which the medication is delivered to the user.
Fig. 2 shows an exploded view of the drive mechanism of the infusion pump. A reservoir assembly <b>15</b> comprises a reservoir <b>30</b>, plunger <b>35</b> and plunger rod <b>40.</b> The reservoir <b>30</b> contains the medication for delivery to the user and is of variable interior volume. The interior volume is the liquid capacity of the reservoir. The plunger <b>35,</b> inserted into the bottom of the reservoir, causes the volume of the reservoir to change as the plunger is displaced along the longitudinal axis of the reservoir. The plunger rod <b>40</b> is connected to the plunger with the rod's longitudinal axis displaced from and parallel to the longitudinal axis of the reservoir. The plunger rod <b>40</b> is threaded for at least a portion of the rod's length. A cylindrical pump barrel <b>45</b> receives the reservoir assembly <b>15.</b> The pump barrel constrains the plunger rod, orienting the rod along the longitudinal axis of the barrel. The pump barrel <b>45</b> is contained in the pump assembly and may contain a locking tab to prevent rotation of the pump barrel with respect to the assembly. A gear box <b>55</b> in the pump assembly <b>15</b> includes a drive screw <b>50</b> along with motor and gears to turn the drive screw. The drive screw <b>50</b> is threaded and the screw's longitudinal axis is aligned parallel to and displaced from the longitudinal axis of the pump barrel. A locking hub <b>25</b> is attached to the top of the reservoir.
Fig. 3 shows a pump barrel locking mechanism for an embodiment of the invention. The pump barrel <b>45</b> includes a clearance hole <b>72</b> in one end (shown in fig. 4) that guides the plunger rod <b>40</b> during insertion of the reservoir assembly <b>15</b> into the barrel. To ensure that the drive screw <b>50</b> does not interfere with the plunger rod <b>40</b> during insertion of the reservoir assembly, the pump barrel <b>45</b> maintains a fixed position relative to the pump assembly <b>10.</b> The position of the pump barrel relative to the pump assembly may be maintained, for example, by a locking tab <b>60</b> included in the pump barrel that engages a pump barrel stop <b>65</b> in the pump assembly <b>10.</b> The hub <b>25</b> may include a flange <b>70</b> which dislodges the locking tab <b>60</b> from the barrel stop 65 when the hub turns, allowing the hub to rotate the pump barrel <b>45.</b>
Figs. 4A and 4B are views along the longitudinal axis of the pump barrel <b>45</b> showing the relation of the drive screw to the plunger rod in a loading position and in an engaged position, respectively. The reservoir assembly <b>15</b> is positioned for loading so that the plunger rod <b>40</b> does not contact the drive screw <b>50,</b> as shown in fig. <b>4A.</b> With the pump barrel positioned appropriately with respect to the pump assembly, the plunger rod clearance from the drive screw is determined by the placement of the clearance hole <b>72</b> in the pump barrel base, which hole receives and guides the plunger rod. The clearance hole may be tapered to ease insertion of the rod. The drive screw <b>50</b> fits in a clearance hole <b>72</b> in the pump barrel <b>45.</b> Once the reservoir assembly <b>15</b> is inserted into the pump assembly <b>10,</b> the barrel <b>45</b> is rotated by the locking hub, causing the plunger rod <b>40</b> to turn and to engage the drive screw <b>50,</b> as shown in fig. <b>4B.</b> This embodiment advantageously simplifies reservoir loading.
In a specific embodiment of the invention, the plunger rod threads and the drive screw threads are buttress threads. This embodiment advantageously addresses eliminating reaction forces on the plunger rod normal to the direction of the rod's longitudinal axis. Such reaction forces may cause the rod to deflect and skip a thread on the drive screw, resulting in under delivery of medication to the user. Buttress threads eliminate the normal component of the reaction force.
In an embodiment of the present invention, the locking hub <b>25</b> may be connected to the reservoir <b>30</b> by a tapered luer connection, as shown in fig. 5. The reservoir has a male luer taper integrally molded into the reservoir's top. Surrounding the male luer is an annulus with an internal female thread. Similarly, the hub <b>25</b> contains the mating female luer and threaded male connection.
In another embodiment of the invention, a needle connection is provided between reservoir <b>30</b> and hub <b>25.</b> As shown in fig. 6, the reservoir includes a rubber septum <b>80</b> that is attached to the reservoir with a crimped metal collar. A needle <b>85,</b> integral to the hub, pierces the septum and fluid can then flow from the reservoir to the tubing set.
In a further embodiment of the invention, as shown in fig. 7, an adapter <b>95</b> is provided to permit a reservoir <b>90</b> whose diameter is substantially smaller than the diameter of the pump barrel <b>45</b> to be used with the pump assembly <b>10.</b> The adapter <b>90</b> may be a separate component or may be integrated into the locking hub <b>25.</b> The adapter <b>95</b> aligns and offsets the reservoir's <b>90</b> axis parallel to the longitudinal axis of the pump barrel so that the plunger rod <b>40,</b> when rotated, mates with the drive screw. Fig 8 shows an on-axis view of the small diameter reservoir <b>90</b> when placed in the adapter <b>95.</b> As will be apparent, the offset provided by the adapter allows the plunger rod <b>40,</b> when mated with the plunger <b>35</b> and reservoir <b>90,</b> to engage the drive screw <b>50</b> in the same fashion as for the first embodiment, described above.
Having described various illustrative embodiments of the present invention, some of its advantages and optional features, it will be apparent that such embodiments are presented by way of example only and not by way of limitation. Those skilled in the art could readily devise alterations and improvements on these embodiments, as well as additional embodiments, without departing from the spirit and scope of the invention. All such modifications are within the scope of the invention as claimed.
9 sheets
Sheet 1 Sheet 2 Sheet 3 Sheet 4 Sheet 5 Sheet 6 Sheet 7 Sheet 8 Sheet 9
Every citation, both ways
| Document | Relation | Office | Cited during |
|---|---|---|---|
| EP0398394A2 | Cites | European Patent Office (EPO) | Search report |
| EP0749757A2 | Cites | European Patent Office (EPO) | Search report |
| US4392847A | Cites | United States of America | Search report |
| US4493704A | Cites | United States of America | Applicant |
| US5507727A | Cites | United States of America | Applicant |
| US5954697A | Cites | United States of America | Applicant |
| US6042565A | Cites | United States of America | Applicant |
204 members in 11 offices
Priority claims9
| Document | Office | Kind | Date |
|---|---|---|---|
| 37614 | United States of America | – | |
| 3761402 | United States of America | A | |
| 3761402 | United States of America | A | |
| 02794414 | European Patent Office (EPO) | A | |
| 02794414 | European Patent Office (EPO) | A | |
| 02794414 | – | – | – |
| 37614 | – | – | – |
| EP20020794414 | – | – | – |
| US20020037614 | – | – | – |
Members204
| Document | Office | Kind | |
|---|---|---|---|
| US2002173769A1 | United States of America | A1 | |
| CA2447182A1 | Canada | A1 | |
| WO02094352A2 | World Intellectual Property Organization (WIPO) | A2 | |
| WO02094352A3 | World Intellectual Property Organization (WIPO) | A3 | |
| US2003130618A1 | United States of America | A1 | |
| CA2472071A1 | Canada | A1 | |
| WO03059420A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU2002359850A1 | Australia | A1 | |
| EP1390089A2 | European Patent Office (EPO) | A2 | |
| MXPA03010576A | Mexico | A | |
| CN1511048A | China | A | |
| EP1461097A1 | European Patent Office (EPO) | A1 | |
| MXPA04006589A | Mexico | A | |
| CN1612759A | China | A | |
| JP2005514176A | Japan | A | |
| JP2005515798A | Japan | A | |
| EP1461097B1 | European Patent Office (EPO) | B1 | |
| EP1666079A2This record | European Patent Office (EPO) | A2 | |
| EP1666079A3 | European Patent Office (EPO) | A3 | |
| AT326991T | Austria | T | |
| ATE326991T1 | Austria | T1 | |
| DE60211748D1 | Germany | D1 | |
| EP1390089B1 | European Patent Office (EPO) | B1 | |
| AT352334T | Austria | T | |
| ATE352334T1 | Austria | T1 | |
| US2007049870A1 | United States of America | A1 | |
| DE60217853D1 | Germany | D1 | |
| CN1306969C | China | C | |
| DE60211748T2 | Germany | T2 | |
| CN1961980A | China | A | |
| DK1390089T3 | Denmark | T3 | |
| EP1815879A2 | European Patent Office (EPO) | A2 | |
| EP1815879A3 | European Patent Office (EPO) | A3 | |
| US7306578B2 | United States of America | B2 | |
| DE60217853T2 | Germany | T2 | |
| CN100369639C | China | C | |
| AU2002359850B2 | Australia | B2 | |
| AU2008246210A1 | Australia | A1 | |
| EP1666079B1 | European Patent Office (EPO) | B1 | |
| AT425779T | Austria | T | |
| ATE425779T1 | Austria | T1 | |
| US2009099523A1 | United States of America | A1 | |
| DE60231666D1 | Germany | D1 | |
| JP2009183729A | Japan | A | |
| CN100542619C | China | C | |
| JP4357297B2 | Japan | B2 | |
| EP2140891A2 | European Patent Office (EPO) | A2 | |
| EP2140891A3 | European Patent Office (EPO) | A3 | |
| CA2739968A1 | Canada | A1 | |
| US2010089475A1 | United States of America | A1 | |
| US2010090843A1 | United States of America | A1 | |
| US2010094215A1 | United States of America | A1 | |
| US2010094220A1 | United States of America | A1 | |
| US2010094221A1 | United States of America | A1 | |
| US2010094222A1 | United States of America | A1 | |
| US2010094261A1 | United States of America | A1 | |
| WO2010042814A2 | World Intellectual Property Organization (WIPO) | A2 | |
| WO2010042814A3 | World Intellectual Property Organization (WIPO) | A3 | |
| EP2258420A2 | European Patent Office (EPO) | A2 | |
| CA2447182C | Canada | C | |
| JP4681795B2 | Japan | B2 | |
| CA2472071C | Canada | C | |
| US2011208123A1 | United States of America | A1 | |
| US8016789B2 | United States of America | B2 | |
| AU2008246210B2 | Australia | B2 | |
| US2011230837A1 | United States of America | A1 | |
| EP2258420A3 | European Patent Office (EPO) | A3 | |
| EP2370126A2 | European Patent Office (EPO) | A2 | |
| US8034026B2 | United States of America | B2 | |
| CA2795049A1 | Canada | A1 | |
| WO2011126895A2 | World Intellectual Property Organization (WIPO) | A2 | |
| US8066672B2 | United States of America | B2 | |
| WO2011126895A9 | World Intellectual Property Organization (WIPO) | A9 | |
| US2012004609A1 | United States of America | A1 | |
| WO2011126895A3 | World Intellectual Property Organization (WIPO) | A3 | |
| US2012071830A1 | United States of America | A1 | |
| US2012083738A1 | United States of America | A1 | |
| JP4961449B2 | Japan | B2 | |
| US8223028B2 | United States of America | B2 | |
| US2012209194A1 | United States of America | A1 | |
| US2012209196A1 | United States of America | A1 | |
| US2012209197A1 | United States of America | A1 | |
| US8262616B2 | United States of America | B2 | |
| US8267892B2 | United States of America | B2 | |
| US2012280817A1 | United States of America | A1 | |
| US2013018316A1 | United States of America | A1 | |
| EP2552514A2 | European Patent Office (EPO) | A2 | |
| US2013066265A1 | United States of America | A1 | |
| EP2140891B1 | European Patent Office (EPO) | B1 | |
| US8409143B2 | United States of America | B2 | |
| US8414536B2 | United States of America | B2 | |
| JP2013523276A | Japan | A | |
| US2013226093A1 | United States of America | A1 | |
| US2013289485A1 | United States of America | A1 | |
| US8632499B2 | United States of America | B2 | |
| US8684972B2 | United States of America | B2 | |
| EP2258420B1 | European Patent Office (EPO) | B1 | |
| US2014114253A1 | United States of America | A1 | |
| US8708376B2 | United States of America | B2 | |
| US8708960B2 | United States of America | B2 |
70 legal events, as 6 offices reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | Office | |
|---|---|---|---|
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Notification of lapseLapsedST | ST | FR | |
| Patent lapsedLapsedMM4A | MM4A | IE | |
| Gb: european patent ceased through non-payment of renewal feeCeasedGBPC | GBPC | EP | |
| Patent ceasedCeasedPL | PL | CH | |
| Application deemed withdrawn, or ip right lapsed, due to non-payment of renewal feeWithdrawnR119 | R119 | DE | |
| Change of the address of the representativeNEW ADDRESS: HOLEESTRASSE 87, 4054 BASEL (CH)PCAR | PCAR | CH | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Fee paymentPLFP | PLFP | FR | |
| Transmission of propertyTP | TP | FR | |
| Amendments to the register in respect of changes of name or changes affecting rights (sect. 32/1977)REGISTERED BETWEEN 20160908 AND 20160914732E | 732E | GB | |
| AssignmentPUE | PUE | CH | |
| Change of applicant/patenteeR081 | R081 | DE | |
| Change of representativeR082 | R082 | DE | |
| Fee paymentPLFP | PLFP | FR | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| No opposition filedOpposition26N | 26N | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| No opposition filed within time limitOppositionORIGINAL CODE: 0009261PLBE | PLBE | EP | |
| Information on the status of an ep patent application or granted ep patentGrantedSTATUS: NO OPPOSITION FILED WITHIN TIME LIMITSTAA | STAA | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Nl: lapsed or annulled due to failure to fulfill the requirements of art. 29p and 29m of the patents actLapsedNLV1 | NLV1 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| New agentNV | NV | CH | |
| Corresponds to:REF | REF | EP | |
| European patents granted designating irelandGrantedFG4D | FG4D | IE | |
| European patent takes effect as a national patent in ch/liEP | EP | CH | |
| Divisional application: reference to earlier applicationAC | AC | EP | |
| Designated contracting statesAK | AK | EP | |
| European patent grantedGrantedFG4D | FG4D | GB | |
| (expected) grantORIGINAL CODE: 0009210GRAA | GRAA | EP | |
| Grant fee paidORIGINAL CODE: EPIDOSNIGR3GRAS | GRAS | EP | |
| Despatch of communication of intention to grant a patentORIGINAL CODE: EPIDOSNIGR1GRAP | GRAP | EP | |
| Designation fees paidAKX | AKX | EP | |
| First examination report despatched17Q | 17Q | EP | |
| Designated contracting statesAK | AK | EP | |
| Request for extension of the european patentAX | AX | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Request for examination filed17P | 17P | EP | |
| Divisional application: reference to earlier applicationAC | AC | EP | |
| Designated contracting statesAK | AK | EP | |
| Request for extension of the european patentAX | AX | EP | |
| Search report despatchedORIGINAL CODE: 0009013PUAL | PUAL | EP | |
| Public reference made under article 153(3) epc to a published international application that has entered the european phaseORIGINAL CODE: 0009012PUAI | PUAI | EP |
Numbers
- Publication
- 1666079
- Publication, DOCDB
- 1666079
- Publication, EPODOC
- EP1666079
- Application
- 6005282
- Application, DOCDB
- 06005282
- Application, EPODOC
- EP20060005282
Titles3
- German
- Lademechanismus für Infusionspumpe
- English
- Loading mechanism for infusion pump
- French
- Mécanisme de chargement d'une pompe à perfusion
Classification
- CPC, 12
- A61M5/1456
- A61M5/14
- A61M5/142
- A61M5/1452
- A61M5/14546
- A61M5/158
- A61M25/0612
- A61M39/1011
- A61M39/14
- A61M2005/14573
- A61M2005/1581
- A61M2005/1587
- IPC, 8
- A61M5 145
- A61M5 158
- A61M5 142
- A61M1 36
- A61M5 14
- A61M25 06
- A61M39 10
- A61M39 14
Designated states30
- Contracting states, 25
- Austria
- Belgium
- Bulgaria
- Switzerland
- Cyprus
- Czechia
- Germany
- Denmark
- Estonia
- Spain
- Finland
- France
- United Kingdom
- Greece
- Ireland
- Italy
- Liechtenstein
- Luxembourg
- Monaco
- Netherlands (Kingdom of the)
- Portugal
- Sweden
- Slovenia
- Slovakia
and 1 moreShow fewer
- Türkiye
- Extension states, 5
- Albania
- Lithuania
- Latvia
- North Macedonia
- Romania